| Name | Title | Contact Details |
|---|---|---|
Jaideep Singh |
Senior Director, CISO, Head of IT Privacy, IT Compliance and Network | Profile |
Katherine Madigan |
Senior Director, Head of Regulatory and R&D Policy | Profile |
Mason Miranda |
Director, R&D IT Solutions, Enterprise Information Technology | Profile |
Tushar Patel |
Vice President, US Commercial (Sales and Marketing), Sleep Wake Franchise | Profile |
Tushar Patel |
Vice President, US Commercial (Sales and Marketing), Sleep Wake Franchise | Profile |
MHC Healthcare is a network of health centers focused on serving the communities where our patients live. We promote and support accessible and affordable primary health care services for all individuals independent of socio-economic status, national o...
Current Operational Status: A Letter from the Executive Director July 6, 2020 These last few [...]
Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company specializing in the development, production and marketing of generic and proprietary branded pharmaceuticals as well as active pharmaceutical ingredients.
Marena offers medical grade compression garments including post op garments, compression shapewear, compression activewear, and more.
ProNAi Therapeutics is a clinical-stage oncology company pioneering a novel class of therapeutics based on its proprietary DNAi technology platform for patients with cancer and hematological diseases. ProNAi`s lead DNAi product candidate, PNT2258, is designed to treat cancers that overexpress BCL2, an important and validated oncogene known to be dysregulated in many types of cancer. ProNAi is pursuing a multi-faceted clinical development strategy designed to efficiently achieve regulatory approval and maximize the commercial opportunity of PNT2258. ProNAi recently initiated "Wolverine", a Phase 2 trial evaluating PNT2258 for the treatment of relapsed or refractory diffuse large B-cell lymphoma.